Fluvoxamine, an inexpensive antidepressant, might help keep patients with COVID-19 from developing severe disease, according to a new study published in The Lancet Global...
PARIS: Most off-label use of antidepressants is not backed by evidence that the drugs will work as intended, scientists said on Wednesday.
Many medications approved...